Author/Authors :
Bagherian, Fatemeh Department of Infectious Diseases - Clinical Research Development Unit - BouAli Sina Hospital - Qazvin University of Medical of Sciences, Qazvin, Iran , Nikoonejad, Alireza Department of Infectious Diseases - Clinical Research Development Unit - Booalisina Hospital - Qazvin University of Medical of Sciences, Qazvin, Iran , Allami, Abbas Department of Infectious Diseases - Clinical Research Development Unit - Booalisina Hospital - Qazvin University of Medical of Sciences, Qazvin, Iran , Dodangeh, Samira Department of Medical Laboratory Techniques - Osoul Aldeen University College, Baghdad, Iraq , Hosienbeigi, Bahram Department of Medical Parasitology and Mycology, Qazvin, Iran
Abstract :
Background and objectives: Antibiotic resistance is a
global health challenge that affects both individuals and the
health system in many ways. The aim of this study was to
evaluate the antibiotic resistance pattern in isolates from patients
admitted to the intensive care unit (ICU) of a hospital in Qazvin,
Iran.
Methods: This descriptive and retrospective study was
performed on urine and blood samples collected from 1318 ICU
patients in the Velayat Hospital of Qazvin (Iran) during 2017-
2019. Data were collected from patients’ medical records. All
statistical analyses were performed using SPSS software (version
25).
Results: Based on the findings, 65.2% of the samples
were related to urinary tract infections and 34.7% to bloodstream
infections. Escherichia coli (68.6%) and Stenotrophomonas
(41.0%) were the most common bacteria isolated from urinary
tract infections and bloodstream infections, respectively.
Moreover, the rate of antibiotic resistance was higher among
Acinetobacter, Escherichia coli, Stenotrophomonas,
Enterococcus and Pseudomonas isolates.
Conclusion: The rate of drug resistance in isolates from
ICU patients is alarmingly high and requires immediate attention.
It is recommended to modify antibiotic prescriptions in the
hospital based on the results of antibiotic resistance pattern,
particularly for treatment of infections caused by E. coli and
Stenotrophomonas.